Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Erelzi Sensoready (Etanercept).
Allergic reactions: In rare cases, some people may develop an allergic reaction to Erelzi Sensoready (Etanercept). Signs of an allergic reaction include a severe rash, hives, swollen face or throat, or difficulty breathing. If these occur, contact your doctor immediately.
Anemia: Erelzi Sensoready (Etanercept) may cause low levels of red blood cells. If you experience symptoms of reduced red blood cell count (anemia) such as shortness of breath, feeling unusually tired, or pale skin, contact your doctor as soon as possible.
Bleeding: Erelzi Sensoready (Etanercept) can cause a reduced number of platelets in the blood, which can make it difficult to stop cuts from bleeding. If you notice any signs of bleeding, such as frequent nosebleeds, unexplained bruising, black and tarry stools, or blood or material that looks like coffee grounds in vomit, notify your doctor as soon as possible. Your doctor will order routine blood tests to make sure potential problems are caught early.
Cancer: Very rarely, people taking Erelzi Sensoready (Etanercept) and similar medications have developed Leukemia or lymphoma, types of blood cancer. In general, people with rheumatoid arthritis or psoriasis who take medications that suppress the immune system over long periods of time may also have a higher risk of developing lymphoma, even if they don't take Erelzi Sensoready (Etanercept). Avoid using Erelzi Sensoready (Etanercept) in combination with Cyclophosphamide. This combination may increase the risk of developing certain types of cancer.
There may be a slightly increased risk of developing Melanoma (a type of Skin Cancer). Report any unusual growths on your skin to your doctor as soon as possible. Your doctor will monitor you for skin cancer while you are taking Erelzi Sensoready (Etanercept). Talk to your doctor if you have any concerns.
Diabetes: Erelzi Sensoready (Etanercept) may cause a decrease in blood sugar levels and glucose tolerance may change. People with diabetes may find it necessary to monitor their blood sugar more frequently while using this medication.
If you have diabetes or are at risk for developing diabetes, discuss with your doctor how Erelzi Sensoready (Etanercept) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Erelzi Sensoready (Etanercept), and whether any special monitoring is needed.
Heart failure: Erelzi Sensoready (Etanercept) may worsen Congestive Heart Failure. If you have heart failure, talk to your doctor about the risks and benefits of using Erelzi Sensoready (Etanercept). Symptoms to watch for include swelling of the feet and ankles and shortness of breath. If you notice these symptoms, contact your doctor immediately.
Hepatitis B: People infected with hepatitis B virus (an infection that can damage the liver) may have a relapse of their condition while taking Erelzi Sensoready (Etanercept). If you are at risk for hepatitis B, your doctor may test you for this infection before starting treatment with Erelzi Sensoready (Etanercept) and will follow your condition closely while you are taking the medication. If you notice symptoms of liver problems, such as abdominal pain, yellow eyes or skin, loss of appetite, fatigue, or dark urine, contact your doctor immediately.
Infections: Erelzi Sensoready (Etanercept) can increase the risk of developing an infection, including serious infections such as sepsis, Chickenpox, fungal infections, and tuberculosis. Before starting Erelzi Sensoready (Etanercept) treatment, your doctor may test to see if you have tuberculosis. If you notice signs of an infection such as fever, chills, pain, swelling, coughing, or pus, contact your doctor as soon as possible. Erelzi Sensoready (Etanercept) should also not be started while you have an active infection. Erelzi Sensoready (Etanercept) should not be used in combination with Anakinra or Abatacept, as these medications can increase the risk of severe infection.
Tell your doctor if you have a history of infections that keep coming back, or other conditions that might increase your risk of infections (e.g., diabetes) or have visited or lived in areas where there is a greater risk of certain kinds of fungal infection (e.g., blastomycosis). While you are taking Erelzi Sensoready (Etanercept), your doctor will monitor you for signs of infection.
Nervous system: Erelzi Sensoready (Etanercept) may cause or worsen nervous system disorders. If you have a history of nervous system disorders, such as Multiple Sclerosis, discuss with your doctor how Erelzi Sensoready (Etanercept) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Erelzi Sensoready (Etanercept), and whether any special monitoring is needed.
If you experience numbness or tingling, weakness in your arms or legs, dizziness, or vision changes while taking Erelzi Sensoready (Etanercept), contact your doctor immediately.
Vaccines: Vaccines (e.g., yellow fever, BCG, Cholera, typhoid, varicella, meningococcal, diphtheria) should not be given while you are taking Erelzi Sensoready (Etanercept). Children should complete the recommended vaccination schedule before receiving their first dose of Erelzi Sensoready (Etanercept).
Pregnancy: There have been no studies on the use of Erelzi Sensoready (Etanercept) by pregnant women. Erelzi Sensoready (Etanercept) crosses the placenta and may affect the developing baby if it is used by the mother during pregnancy. For this reason, Erelzi Sensoready (Etanercept) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Erelzi Sensoready (Etanercept), contact your doctor immediately.
Breast-feeding: Erelzi Sensoready (Etanercept) passes into breast milk. If you are breast-feeding and are taking Erelzi Sensoready (Etanercept), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of this medication have not been established for children less than 4 years of age. It can be used to treat children aged 4 to 17 years who have moderate-to-severe juvenile idiopathic arthritis or chronic severe plaque psoriasis.
Seniors: It is likely that seniors will experience more side effects of Erelzi Sensoready (Etanercept), particularly infections. Report any unusual effects or more frequent infections to your doctor as soon as possible.